2021 American Transplant Congress
Impact of New Onset Diabetes After Transplantation on Heart Transplant Recipients
*Purpose: The purpose of this study is to investigate New Onset Diabetes After Transplantation (NODAT) incidence and its impact on post-transplant prognosis in adult heart…2021 American Transplant Congress
Allograft Discard Risk Index for Heart Transplantation
*Purpose: The number of patients awaiting heart transplantation (HTx) substantially exceeds the number of donor hearts transplanted each year, yet nearly 70% of consented donor…2021 American Transplant Congress
Outcomes of HLA Antibody Surveillance Protocol in Heart Transplant Patients – A Single-Center Retrospective Analysis
Baylor University Medical Center, Dallas, TX
*Purpose: Post-transplant care is multifaceted with protocols to provide oversight and maintain the standard of care. While institutional protocols for post-transplant HLA antibody surveillance after…2021 American Transplant Congress
Liver Biopsy as a Predictor in Risk Stratification for Heart Transplant Candidates
*Purpose: Patients undergoing workup for Orthotopic Heart Transplant (OHT) undergo multi-organ evaluation for risk stratification. While cirrhosis is a known predictor of poor outcomes in…2021 American Transplant Congress
Impact of a Pharmacist in an Outpatient Heart Transplant Clinic
1UNC Health Care, Chapel Hill, NC, 2Eshelman School of Pharmacy, Chapel Hill, NC
*Purpose: Data describing the impact of a pharmacist in ambulatory medication management of heart transplant recipients (HTRs) is lacking. Following the addition of an ambulatory…2021 American Transplant Congress
Significance of Repeated 1r Rejections in Heart Transplantation
1Yale New Haven Hospital, New Haven, CT, 2Yale University School of Medicine, New Haven, CT
*Purpose: 1R rejection is commonly seen in routine post-transplant biopsies. While presence of occasional 1R rejection is not considered to be detrimental, the significance of…2021 American Transplant Congress
Combined Heart-liver Transplantation in Patients with Familial Amyloidosis – Analysis of Optn/Unos Database
Virginia Commonwealth University, Richmond, VA
*Purpose: We compared the outcomes after combined heart-liver transplant (CHLT) for patients with Familial Amyloidosis (FA) versus other indications (primary cardiac:congenital heart disease and idiopathic…2021 American Transplant Congress
Management of Drug Interactions During Protocolized Implementation of Posaconazole Immediately Post Heart Transplant
Massachusetts General Hospital, Boston, MA
*Purpose: Posaconazole (POSA) is a strong CYP3A4 inhibitor known to increase tacrolimus exposure by up to 4-fold. Initiation requires empiric tacrolimus dose adjustment and close…2021 American Transplant Congress
Primary Graft Dysfunction in a Risk-Stratified vs. Routine Induction Protocol in Heart Transplant Recipients
*Purpose: Treatment of left ventricular primary graft dysfunction (PGD-LV) is supportive in nature. We aim to evaluate whether a change in induction protocol from a…2020 American Transplant Congress
C-Reactive Protein 1-Year Post-Transplant is Associated with Future Development of Coronary Artery Vasculopathy and Rejection in a Pediatric Heart Transplant Cohort
Congenital Heart Center/Pediatrics, University of Florida, Gainesville, FL
*Purpose: Coronary artery vasculopathy (CAV) is one of the leading causes of mortality beyond 3y post-transplant (OHT). Multiple risk factors are associated with development of…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 30
- Next Page »